Heterogeneity of diagnosis, treatment, and management for immune thrombotic thrombocytopenic purpura: Are we still peering through the looking glass?

J Clin Apher. 2020 Jun;35(3):236-237. doi: 10.1002/jca.21777. Epub 2020 May 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • ADAMTS13 Protein / blood
  • ADAMTS13 Protein / deficiency
  • ADAMTS13 Protein / immunology
  • Biomarkers / blood
  • Humans
  • Plasma Exchange
  • Practice Guidelines as Topic
  • Purpura, Thrombocytopenic, Idiopathic* / diagnosis
  • Purpura, Thrombocytopenic, Idiopathic* / immunology
  • Purpura, Thrombocytopenic, Idiopathic* / therapy
  • Purpura, Thrombotic Thrombocytopenic* / diagnosis
  • Purpura, Thrombotic Thrombocytopenic* / immunology
  • Purpura, Thrombotic Thrombocytopenic* / therapy
  • Surveys and Questionnaires

Substances

  • Biomarkers
  • ADAMTS13 Protein
  • ADAMTS13 protein, human